Reasons for cannabis use in first-episode psychosis: Does strength of endorsement change over 12 months?

European Psychiatry

Volumn 30, Issue 1, 2015, Pages 152-159

  Kolliakou, A ^a   Castle, D ^b   Sallis, H ^c   Joseph, C ^a   O'Connor, J ^a   Wiffen, B ^a   Gayer Anderson, C ^a   McQueen, G ^a   Taylor, H ^a   Bonaccorso, S ^a   Gaughran, F ^a   Smith, S ^a   Greenwood, K ^d   Murray, R M ^a   Di Forti, M ^a   Atakan, Z ^a   Ismail, K ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

^d UNIVERSITY OF SUSSEX   (United Kingdom)

Author keywords

Alleviation of dysphoria; Cannabis use; Psychosis; Reasons for cannabis use; Schizophrenia; Self medication

Indexed keywords

CANNABIS;

ADULT; AGED; ARTICLE; CANNABIS USE; CONFORMITY AND ACCEPTANCE; CONTROLLED STUDY; COPING WITH UNPLEASANT AFFECT; DYSPHORIA; ENHANCEMENT; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MENTAL PATIENT; MOTIVATION; OUTPATIENT; PRIORITY JOURNAL; PSYCHOSIS; RATING SCALE; REASON FOR USE SCALE; RELIEF OF POSITIVE SYMPTOM AND SIDE EFFECT; SELF MEDICATION; SOCIAL ASPECT; SOCIAL MOTIVE; SOCIAL PSYCHOLOGY; SUBSTANCE ABUSE; ADAPTIVE BEHAVIOR; CANNABIS ADDICTION; CANNABIS SMOKING; ENGLAND; EPIDEMIOLOGY; FEMALE; MALE; MIDDLE AGED; PSYCHOLOGY; PSYCHOTIC DISORDERS; SOCIAL BEHAVIOR;

ADAPTATION, PSYCHOLOGICAL; ADULT; AGED; ENGLAND; FEMALE; HUMANS; MALE; MARIJUANA ABUSE; MARIJUANA SMOKING; MIDDLE AGED; MOTIVATION; PSYCHOTIC DISORDERS; SOCIAL BEHAVIOR;

EID: 84921024870     PISSN: 09249338     EISSN: 17783585     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2014.10.007     Document Type: Article

References (50)

1. Addington J., Duchak V. Reasons for substance use in schizophrenia. Acta Psychiatr Scand 1997, 96:329-333.
2. Archie S., Boydell K.M., Stasiulis E., Volpe T., Gladstone B.M. Reflections of young people who have had a first episode of psychosis: what attracted them to use alcohol and illicit drugs?. Early Interv Psychiatry 2013, 7(2):193-199.
3. Bahorik A.L., Newhill C.E., Queen C.C., Eack S.M. Under-reporting of drug use among individuals with schizophrenia: prevalence and predictors. Psychol Med 2014, 44(1):61-69.
4. Baigent M., Holme G., Hafner R.J. Self-reports of the interaction between substance abuse and schizophrenia. Aust N Z J Psychiatry 1995, 29(1):69-74.
5. Barnett J.H., Werners U., Secher S.M., Hill K.E., Brazil R., Masson K., et al. Substance use in a population-based clinic sample of people with first-episode psychosis. Br J Psychiatry 2007, 190:515-520.
6. Cooper M.L. Motivations for alcohol use among adolescents: development and validation of a four-factor model. Psychol Assess 1994, 6:117-128.
7. Dixon L., Haas G., Weiden P.J., Sweeney J., Frances A.J. Drug abuse in schizophrenic patients: clinical correlates and reasons for use. Am J Psychiatry 1991, 148:224-230.
8. Donovan D.M., Bigelow G.E., Brigham G.S., Carroll K.M., Cohen A.J., Gardin J.G., et al. Primary outcome indices in illicit drug dependence treatment research: systematic approach to selection and measurement of drug use end-points in clinical trials. Addiction 2012, 107(4):694-708.
9. Fowler I.L., Carr V.J., Carter N.T., Lewin T.J. Patterns of current and lifetime substance use in schizophrenia. Schizophr Bull 1998, 24:443-445.
10. Goswami S., Mattoo S.K., Basu D., Sing G. Substance-abusing schizophrenics: do they self-medicate?. Am J Addict 2004, 13:139-150.
11. Grech A., Van Os J., Jones P.B., Lewis S.W., Murray R.M. Cannabis use and outcome of recent onset psychosis. Eur Psychiatry 2005, 20(4):349-353.
12. Green B., Kavanagh D.J., Young R.M.C.D. Reasons for cannabis use in men with or without psychosis. Drug Alcohol Rev 2004, 23:445-453.
13. Green B., Young R., Kavanagh D. Cannabis use and misuse prevalence among people with psychosis. Br J Psychiatry 2005, 187:306-313.
14. Gregg L., Barrowclough C., Haddock G. Reasons for increased substance use in psychosis. Clin Psychol Rev 2007, 27:494-510.
15. Gregg L., Haddock G., Barrowclough C. Self-reported reasons for substance use in schizophrenia: a Q methodological investigation. Ment Health Subst Use 2009, 2(1):24-39.
16. Harrison I., Joyce E.M., Mutsatsa S.H., Hutton S.B., Huddy V., Kapasi M., et al. Naturalistic follow-up of co-morbid substance use in schizophrenia: the West London first-episode study. Psychol Med 2007, 38:79-88.
17. Hides L., Dawe S., Kavanagh D.J., Young R.M. Psychotic symptom and cannabis relapse in recent-onset psychosis. Prospective study. Br J Psychiatry 2006, 189:137-143.
18. Kay S.R., Fiszbein A., Opler L.A. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 1987, 13:261-276.
19. Khantzian E.J. The self-medication hypothesis of addictive disorders. Am J Psychiatry 1985, 142:1259-1264.
20. Khantzian E.J. The self-medication hypothesis of substance use disorders: a reconsideration and recent applications. Harv Rev Psychiatry 1997, 4:231-244.
21. Kolliakou A., Joseph C., Atakan A., Ismail K., Murray R.M. Why do patients with psychosis use cannabis and are they ready to change their use?. Int J Dev Neurosci 2011, 29:335-346.
22. Kolliakou A., Ismail K., Fusar-Poli P., Atakan Z. Why do psychotic patients use cannabis? Case series. Curr Pharm Des 2012, 18:4950-4959.
23. Kot T., Serper M. Increased susceptibility to auditory conditioning in hallucinating schizophrenic patients: a preliminary investigation. J Nerv Ment Dis 2002, 190:282-288.
24. Laudet A.B., Magura S., Vogel H.S., Knight E.L. Perceived reasons for substance misuse among persons with a psychiatric disorder. Am J Orthopsychiatry 2004, 74(3):365-375.
25. Leucht S., Kane J.M., Kissling W., Hamann J., Etscel E., Engel R.R. What does the PANSS mean?. Schizophr Res 2005, 79(2-3):231-238.
26. Linszen D.H., Dingemans P.M., Lenior M.E. Cannabis abuse and the course of recent-onset schizophrenic disorders. Arch Gen Psychiatry 1994, 51(4):273-279.
27. McCreadie R.G. Use of drugs, alcohol and tobacco by people with schizophrenia: case-control study. Br J Psychiatry 2002, 181:321-325.
28. McHugo G.J., Drake R.E., Brunette M.F., Haiyi Xie, Essok S.M., Green A.I. Enhancing validity in co-occurring disorders treatment research. Schizophr Bull 2006, 32(4):655-665.
29. Miles H., Johnson S., Amponsah-Afuwape S., Finch E., Leese M., Thornicroft G. Characteristics of subgroups of individuals with psychotic illness and a comorbid substance use disorder. Psychiatr Serv 2003, 54:554-561.
30. Mueser K.T., Drake R.E., Wallach M.A. Dual diagnosis: a review of etiological theories. Addict Behav 1998, 23(6):717-734.
31. Statistical Package for the Social Sciences. Version 20 for Windows 2011, SPSS Inc, Chicago.
32. Pencer A., Addington J. Reasons for using substances in adolescents with and without psychosis. Early Interv Psychiatr 2008, 2:42-44.
33. Pérez L.G., Santacana A.M., Baquero D.B., Pérez-Solá V. Reasons and subjective effects of cannabis use among people with psychotic disorders: a systematic review. Actas Esp Psiquiatr 2014, 42(2):83-90.
34. Regier D.A., Farmer M.E., Rae D.S., Locke B.Z., Keith S.J., Judd L.L., et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) study. JAMA 1990, 264:2511-2518.
35. Schaub M., Fanghaenel K., Stohler R. Reasons for cannabis use: patients with schizophrenia versus matched healthy controls. Aust N Z J Psychiatry 2008, 42:1060-1065.
36. Schneier F.R., Siris S.G. A review of psychoactive substance use and abuse in schizophrenia patterns of drug choice. J Nerv Ment Dis 1987, 175(11):641-652.
37. Schofield D., Tennant C., Nash L., Degenhardt L., Cornish A., Hobbs C., et al. Reasons for cannabis use in psychosis. Aust N Z J Psychiatry 2006, 40:570-574.
38. Seddon L.J., Copello A., Birchwood M. Cannabis use and abstention in first-episode psychosis: the participants' view. Mental Health Subst Use 2013, 6(1):47-58.
39. Selten J.P., Bosman I.J., de Boer D., Veen N.D., van der Graaf Y., Maes R.A., et al. Hair analysis for cannabinoids and amphetamines in a psychosis incidence study. Eur Neuropsychopharmacol 2002, 12:27-30.
40. Sevy S., Robinson D.G., Solloway S., Alvir J.M., Woerner M.G., Bilder R., et al. Correlates of substance misuse in patients with first-episode schizophrenia and schizoaffective disorder. Acta Psychiatr Scand 2001, 104:367-374.
41. Sorbara F., Liraud F., Assens F., Abalan F., Verdoux H. Substance use and the course of early psychosis: a 2-year follow-up of first-admitted subjects. Eur Psychiatry 2003, 18:133-136.
42. Spencer C., Castle D., Michie P.T. Motivations that maintain substance use among individuals with psychotic disorders. Schizophr Bull 2002, 28(2):233-247.
43. Spencer C., Castle D., Michie P.T. Motivations that maintain substance use among individuals with psychotic disorders. Schizophr Bull 2002, 28:233-247.
44. Swartz M.S., Swanson J.W., Hannon M.J. Detection of illicit substance use among persons with schizophrenia by radioimmunoassay of hair. Psychiatr Serv 2003, 54(6):891-895.
45. Swendsen J., Ben-Zeev D., Granholm E. Real-time electronic ambulatory monitoring of substance use and symptom expression in schizophrenia. Am J Psychiatry 2011, 168(2):202-209.
46. Test M.A., Wallisch L.S., Allness D.J., Ripp K. Substance use in young adults with schizophrenic disorders. Schizophr Bull 1989, 15(3):465-476.
47. Thornton L.K., Baker A.L., Lewin T.J., Kay-Lambkin F.J., Kavanagh D., Richmond R., et al. Reasons for substance use among people with mental disorders. Addict Behav 2012, 37:427-434.
48. Tietz N.W. Textbook of Clinical Chemistry 1986, W.B.Saunders Company.
49. Wolford G.L., Rosenberg S.D., Drake R.E., Mueser K.T., Oxman T.E., Hoffman D., et al. Evaluation of methods for detecting substance use disorder in persons with severe mental illness. Psychol Addict Behav 1999, 13:313-326.
50. Zammit S., Moore T.H., Lingford-Huges A., Barnes T.R., Jones P.B., Burke M., et al. Effects of cannabis use on outcomes of psychotic disorders: systematic review. Br J Psychiatry 2008, 193(5):357-363.